DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients

European Journal of Cancer

Volumn 43, Issue 17, 2007, Pages 2479-2486

  Borentain, Patrick ^a   Gérolami, Victoria ^a   Ananian, Pascal ^a   Garcia, Stéphane ^b   Noundou, Anderson ^c   Botta Fridlund, Daniele ^a   Le Treut, Yves Patrice ^a   Bergé Lefranc, Jean Louis ^a   Gérolami, René ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

^b HÔPITAL NORD   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Genetic polymorphism; Glutathione S transferase M1; Hepatocellular carcinoma; Liver transplantation; UDP glucuronosyltransferase 1A7; X Ray Cross Complementing group 1

Indexed keywords

GLUCURONOSYLTRANSFERASE 1A7; GLUTATHIONE TRANSFERASE M1; NUCLEAR PROTEIN; UNCLASSIFIED DRUG; X RAY CROSS COMPLEMENTING 1; XENOBIOTIC AGENT;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK FACTOR;

CARCINOGENS; CARCINOMA, HEPATOCELLULAR; DNA REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; ELECTROPHORESIS, AGAR GEL; FEMALE; GENE AMPLIFICATION; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 36048981862     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.08.006     Document Type: Article

References (40)

1. Llovet J.M., and Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol 38 (2003) S136-S149
2. Yu M.C., and Yuan J.M. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 127 (2004) S72-S78
3. Davila J.A., Morgan R.O., Shaib Y., McGlynn K.A., and El-Serag H.B. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127 (2004) 1372-1380
4. El-Serag H.B. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127 (2004) S27-S34
5. Wells P.G., Mackenzie P.I., Chowdhury J.R., et al. Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos 32 (2004) 281-290
6. Strassburg C.P., Vogel A., Kneip S., Tukey R.H., and Manns M.P. Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 50 (2002) 851-856
7. Butler L.M., Duguay Y., Millikan R.C., et al. Joint effects between UDP-glucuronosyltransferase 1A7 genotype and dietary carcinogen exposure on risk of colon cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 1626-1632
8. Ockenga J., Vogel A., Teich N., Keim V., Manns M.P., and Strassburg C.P. UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 124 (2003) 1802-1808
9. Vogel A., Kneip S., Barut A., et al. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology 121 (2001) 1136-1144
10. Wang Y., Kato N., Hoshida Y., et al. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in japanese patients with hepatitis C virus infection. Clin Cancer Res 10 (2004) 2441-2446
11. Tseng C.S., Tang K.S., Lo H.W., Ker C.G., Teng H.C., and Huang C.S. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age. Am J Gastroenterol 100 (2005) 1758-1763
12. Halangk J., Berg T., Puhl G., et al. Role of UGT1A7 polymorphisms in the development of hepatocellular carcinoma : An example of pitfalls in genotyping. Hepatology 42 (2005) 392A Abstract
13. Rebbeck T.R. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6 (1997) 733-743
14. Hayes J.D., and Strange R.C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61 (2000) 154-166
15. Eaton D.L., Bammler T.K., and Kelly E.J. Interindividual differences in response to chemoprotection against aflatoxin-induced hepatocarcinogenesis: implications for human biotransformation enzyme polymorphisms. Adv Exp Med Biol 500 (2001) 559-576
16. Gelatti U., Covolo L., Talamini R., et al. N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case-control study. Int J Cancer 115 (2005) 301-326
17. Ladero J.M., Martinez C., Garcia-Martin E., et al. Glutathione S-transferase M1 and T1 genetic polymorphisms are not related to the risk of hepatocellular carcinoma: a study in the Spanish population. Eur J Cancer 42 (2006) 73-77
18. Zindy P., Andrieux L., Bonnier D., et al. Upregulation of DNA repair genes in active cirrhosis associated with hepatocellular carcinoma. FEBS Lett 579 (2005) 95-99
19. Yu Z., Chen J., Ford B.N., Brackley M.E., and Glickman B.W. Human DNA repair systems: an overview. Environ Mol Mutagen 33 (1999) 3-20
20. Ford B.N., Ruttan C.C., Kyle V.L., Brackley M.E., and Glickman B.W. Identification of single nucleotide polymorphisms in human DNA repair genes. Carcinogenesis 21 (2000) 1977-1981
21. Bartsch H., Dally H., Popanda O., Risch A., and Schmezer P. Genetic risk profiles for cancer susceptibility and therapy response. Recent Results Cancer Res 174 (2007) 19-36
22. Gao W.M., Romkes M., Siegfried J.M., Luketich J.D., and Keohavong P. Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers. Mol Carcinog 45 (2006) 828-832
23. Breast Cancer Association, C. Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst 2006; 98: 1382-96.
24. Figueroa J.D., Malats N., Real F.X., et al. Genetic variation in the base excision repair pathway and bladder cancer risk. Hum Genet 121 (2007) 233-242
25. Liu G., Zhou W., Yeap B.Y., et al. XRCC1 and XPD Polymorphisms and Esophageal Adenocarcinoma Risk. Carcinogenesis 28 (2007) 1254-1258
26. Stern M.C., Umbach D.M., van Gils C.H., Lunn R.M., and Taylor J.A. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 10 (2001) 125-131
27. Yu M.W., Yang S.Y., Pan I.J., et al. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 95 (2003) 1485-1488
28. Kirk G.D., Turner P.C., Gong Y., et al. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Cancer Epidemiol Biomarkers Prev 14 (2005) 373-379
29. Chen C.C., Yang S.Y., Liu C.J., et al. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol 34 (2005) 1310-1318
30. Long X.D., Ma Y., Wei Y.P., and Deng Z.L. The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatol Res 36 (2006) 48-55
31. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
32. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22: 983-93.
33. Newton C.R., Graham A., Heptinstall L.E., et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 17 (1989) 2503-2516
34. Ganne-Carrie N., Chastang C., Chapel F., et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology 23 (1996) 1112-1118
35. Fattovich G., Stroffolini T., Zagni I., and Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127 (2004) S35-S50
36. Yu M.W., Gladek-Yarborough A., Chiamprasert S., Santella R.M., Liaw Y.F., and Chen C.J. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 109 (1995) 1266-1273
37. Chen C.J., Yu M.W., Liaw Y.F., et al. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet 59 (1996) 128-134
38. Freeman R.B., Mithoefer A., Ruthazer R., et al. Optimizing staging for hepatocellular carcinoma before liver transplantation: A retrospective analysis of the UNOS/OPTN database. Liver Transpl 12 (2006) 1504-1511
39. Grasso A., Stigliano R., Morisco F., et al. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Transplantation 81 (2006) 1532-1541
40. Khakhar A., Solano E., Stell D., et al. Survival after liver transplantation for hepatocellular carcinoma. Transplant Proc 35 (2003) 2438-2441